(Q34164119)

31 July 2017

1 reference

title

Cardiovascular risk in type 2 diabetes (English)

1 reference

31 July 2017

1 reference

1 reference

Standl E

1

1 reference

31 July 2017

1 September 1999

1 reference

Diabetes, Obesity and Metabolism

31 July 2017

1 reference

31 July 2017

1 Suppl 2

1 reference

31 July 2017

S24-36

1 reference

Insulin resistance implications for type II diabetes mellitus and coronary heart disease

31 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

Development of vascular complications in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

The U.K. Prospective Diabetes Study. A review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

Hyperglycemia and microvascular and macrovascular disease in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

Postprandial hyperglycaemia and alpha-glucosidase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

Associations of hypertension and complications in non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

Lipid disorders in NIDDM: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

Markers of insulin resistance are associated with cardiovascular morbidity and predict overall mortality in long-standing non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

Body weight: implications for the prevention of coronary heart disease, stroke, and diabetes mellitus in a cohort study of middle aged men

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

Science, medicine, and the future. Obesity treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

The efficacy and safety of miglitol therapy compared with glibenclamide in patients with NIDDM inadequately controlled by diet alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

New treatments for patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

Long-term effectiveness of a new alpha-glucosidase inhibitor (BAY m1099-miglitol) in insulin-treated type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

Coronary artery disease and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

Lipids, thrombosis and cardiovascular disease in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

Clustering of cardiovascular risk factors: targeting high-risk individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

Glucose tolerance and coronary heart disease: Helsinki Policemen Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

Quality of life in diabetic patients registered with primary health care services in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

Using continuous quality improvement to improve diabetes care in populations: the IDEAL model. Improving care for Diabetics through Empowerment Active collaboration and Leadership

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

Calcium channel blockers. The jury is still out on whether they cause heart attacks and suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

Metabolic Control and Prevalent Cardiovascular Disease in Non-Insulin-dependent Diabetes Mellitus (NIDDM): The NIDDM Patient Outcomes Research Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.1999.0010S2024.X

10.1046/J.1463-1326.1999.0010S2024.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11221799